KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Goodwill (2016 - 2025)

AbbVie (ABBV) has disclosed Goodwill for 14 consecutive years, with $35.3 billion as the latest value for Q1 2025.

  • On a quarterly basis, Goodwill changed N/A to $35.3 billion in Q1 2025 year-over-year; TTM through Mar 2025 was $35.3 billion, a N/A change, with the full-year FY2024 number at $35.0 billion, up 8.25% from a year prior.
  • Goodwill was $35.3 billion for Q1 2025 at AbbVie, up from $35.0 billion in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $35.3 billion in Q3 2024 to a low of $31.7 billion in Q3 2022.
  • A 5-year average of $33.0 billion and a median of $32.3 billion in 2023 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: dropped 2.25% in 2021, then grew 9.98% in 2024.
  • AbbVie's Goodwill stood at $32.4 billion in 2021, then decreased by 0.69% to $32.2 billion in 2022, then grew by 0.43% to $32.3 billion in 2023, then rose by 8.25% to $35.0 billion in 2024, then increased by 0.94% to $35.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Goodwill are $35.3 billion (Q1 2025), $35.0 billion (Q4 2024), and $35.3 billion (Q3 2024).